Georg M Wieselthaler

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. doi request reprint Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial
    Georg M Wieselthaler
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna General Hospital, Waehringer Guertel 18 20, Vienna, Austria
    J Heart Lung Transplant 29:1218-25. 2010
  2. doi request reprint Renal function and outcome after continuous flow left ventricular assist device implantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    Ann Thorac Surg 87:1072-8. 2009
  3. doi request reprint Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    J Heart Lung Transplant 28:367-72. 2009
  4. doi request reprint Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    Artif Organs 32:819-22. 2008
  5. doi request reprint Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    J Heart Lung Transplant 27:469-73. 2008
  6. ncbi request reprint The DuraHeart VAD, a magnetically levitated centrifugal pump: the University of Vienna bridge-to-transplant experience
    Tomohiro Nishinaka
    Department of Cardiothoracic Surgery, Medical University of Vienna, A 1090 Vienna, Austria
    Circ J 70:1421-5. 2006
  7. ncbi request reprint Endocrine function is not impaired in patients with a continuous MicroMed-DeBakey axial flow pump
    Georg M Wieselthaler
    Department of Cardiothoracic Surgery, University of Vienna, Vienna, Austria
    J Thorac Cardiovasc Surg 133:2-6. 2007
  8. ncbi request reprint Special considerations on the implantation technique for the MicroMed-DeBakey ventricular assist device axial pump
    Georg M Wieselthaler
    Department of Cardiothoracic Surgery and Ludwig Boltzmann Institute for Cardiosurgical Research, University of Vienna, Vienna, Austria
    Ann Thorac Surg 76:2109-11. 2003
  9. ncbi request reprint Extensive coagulation monitoring in patients after implantation of the MicroMed Debakey continuous flow axial pump
    Nikolaos Bonaros
    Department of Cardiothoracic Surgery, University of Vienna, Austria
    ASAIO J 50:424-31. 2004

Detail Information

Publications9

  1. doi request reprint Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial
    Georg M Wieselthaler
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna General Hospital, Waehringer Guertel 18 20, Vienna, Austria
    J Heart Lung Transplant 29:1218-25. 2010
    ..Recently, the novel HVAD pump (HeartWare Inc, Framingham, MA), a miniaturized centrifugal pump with a hydrodynamic, magnetically levitated rotor, became ready for clinical application...
  2. doi request reprint Renal function and outcome after continuous flow left ventricular assist device implantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    Ann Thorac Surg 87:1072-8. 2009
    ..Renal dysfunction as a risk factor with the use of left ventricular assist devices (LVAD) is controversial. We determined the effect of renal function on outcomes after continuous flow LVAD implantation...
  3. doi request reprint Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    J Heart Lung Transplant 28:367-72. 2009
    ..The effect of age on outcomes after continuous-flow left ventricular assist device (LVAD) implantation as a bridge to transplantation (BTT) was determined...
  4. doi request reprint Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    Artif Organs 32:819-22. 2008
    ..In two patients, pump thrombosis was suspected. There were two ischemic and no hemorrhagic strokes. The use of LMWH may provide a new anticoagulation treatment option in the immediate postoperative period after LVAD implantation...
  5. doi request reprint Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    J Heart Lung Transplant 27:469-73. 2008
    ..This study was designed to determine the effect of continuous vs pulsatile flow devices on renal function after left ventricular assist device (LVAD) implantation...
  6. ncbi request reprint The DuraHeart VAD, a magnetically levitated centrifugal pump: the University of Vienna bridge-to-transplant experience
    Tomohiro Nishinaka
    Department of Cardiothoracic Surgery, Medical University of Vienna, A 1090 Vienna, Austria
    Circ J 70:1421-5. 2006
    ..The clinical application of the DuraHeart (Terumo Heart Inc, USA) has begun in Europe as a clinical trial of a third-generation implantable centrifugal blood pump. Four successful clinical implants are presented...
  7. ncbi request reprint Endocrine function is not impaired in patients with a continuous MicroMed-DeBakey axial flow pump
    Georg M Wieselthaler
    Department of Cardiothoracic Surgery, University of Vienna, Vienna, Austria
    J Thorac Cardiovasc Surg 133:2-6. 2007
    ..Patients with implanted MicroMed-DeBakey axial pumps show nonphysiologic low-pulsatile blood flow profiles, and therefore it appeared to be of interest to evaluate their possible effect on the endocrine system...
  8. ncbi request reprint Special considerations on the implantation technique for the MicroMed-DeBakey ventricular assist device axial pump
    Georg M Wieselthaler
    Department of Cardiothoracic Surgery and Ludwig Boltzmann Institute for Cardiosurgical Research, University of Vienna, Vienna, Austria
    Ann Thorac Surg 76:2109-11. 2003
    ..3 +/- 0.6 to 6.7 +/- 0.3 L/min), and to facilitate the subsequent transplantation...
  9. ncbi request reprint Extensive coagulation monitoring in patients after implantation of the MicroMed Debakey continuous flow axial pump
    Nikolaos Bonaros
    Department of Cardiothoracic Surgery, University of Vienna, Austria
    ASAIO J 50:424-31. 2004
    ..Aspirin and dipyridamole therapy in addition to oral anticoagulation using phenprocoumon may contribute to platelet function and clot mechanics restoration and is, therefore, recommended for patients after VAD implantation...